Lam Research (NASDAQ:LRCX) Trading Down 4.3% – Here’s Why

Lam Research Corporation (NASDAQ:LRCX)’s stock price traded down 4.3% during mid-day trading on Thursday . The company traded as low as $208.00 and last traded at $209.49. 9,091,333 shares changed hands during mid-day trading, a decline of 25% from the average session volume of 12,146,335 shares. The stock had previously closed at $218.87.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam announced a long‑term collaboration with IBM to advance sub‑1nm logic scaling (materials, processes and High‑NA EUV), reinforcing Lam’s role in next‑generation AI and logic chip roadmaps — this supports long‑term growth expectations. Lam Research IBM Alliance Targets Sub 1nm Logic And AI Chip Demand
• Positive Sentiment: Analysts are raising estimates and price targets (Barclays bullish update; an analyst upgrade drove an intraday lift), which supports upside sentiment and institutional demand. Barclays Forecasts Strong Price Appreciation for Lam Research
• Positive Sentiment: Recent earnings beat and strong AI/advanced packaging demand underpin a stronger revenue/EPS outlook; one note highlights a ~33% three‑month rally driven by those fundamentals. That momentum still supports medium‑term upside if WFE (wafer fab equipment) spending stays robust. LRCX Stock Soars 33% in Three Months
• Positive Sentiment: Industry analysis and company commentary point to a supply‑constrained WFE cycle that could create a multi‑year revenue runway for equipment suppliers like Lam. Lam Research: Supply-Constrained WFE Cycle Sets Up A Multi-Year Runway
• Positive Sentiment: Short interest has declined materially in February (down ~20.7% vs. mid‑Feb), which can reduce downward pressure from short squeezes and indicates fewer bearish bets outstanding.
• Neutral Sentiment: Industry‑wide trends (higher chip gear spending forecasts) are positive for the group but create correlated moves across peers; Lam’s stock can be moved by sector flows as much as company news. Chip Gear Spending Shows No Signs Of Slowing, Analyst Says
• Neutral Sentiment: Reports show some hedge funds increasing short exposure amid geopolitical and credit worries; this is a macro hedge that can amplify volatility but doesn’t target Lam specifically. Hazeltree Finds Hedge Funds Ramp Up Short Bets
• Negative Sentiment: Valuation concerns: some analysts/commentators argue the recent rally has stretched valuation and that the stock may need to “come back to earth,” which supports profit‑taking and pressure on near‑term performance. Lam Research: Wonderful Company, But The Price Needs To Come Back To Earth

Analysts Set New Price Targets

Several research analysts have recently weighed in on LRCX shares. Summit Insights upgraded Lam Research from a “hold” rating to a “buy” rating in a research note on Thursday, January 29th. Jefferies Financial Group restated a “buy” rating and issued a $200.00 price objective (up from $175.00) on shares of Lam Research in a research note on Monday, December 15th. Wells Fargo & Company upped their price objective on shares of Lam Research from $250.00 to $290.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. Citigroup increased their target price on shares of Lam Research from $265.00 to $300.00 and gave the stock a “buy” rating in a research report on Thursday, January 29th. Finally, Sanford C. Bernstein boosted their price target on shares of Lam Research from $275.00 to $285.00 and gave the company an “outperform” rating in a research report on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $245.35.

Lam Research Price Performance

The business has a fifty day moving average of $223.44 and a 200-day moving average of $171.66. The firm has a market cap of $261.60 billion, a PE ratio of 42.93, a PEG ratio of 2.32 and a beta of 1.77. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business had revenue of $5.34 billion during the quarter, compared to analyst estimates of $5.23 billion. During the same quarter in the previous year, the firm earned $0.91 EPS. The company’s quarterly revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, research analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, March 4th. This represents a $1.04 annualized dividend and a yield of 0.5%. Lam Research’s payout ratio is currently 21.31%.

Insider Buying and Selling

In other Lam Research news, Director Eric Brandt sold 35,000 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $225.60, for a total value of $7,896,000.00. Following the sale, the director directly owned 253,705 shares in the company, valued at $57,235,848. This represents a 12.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of the firm’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the transaction, the chief financial officer directly owned 1,081,705 shares of the company’s stock, valued at approximately $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 130,886 shares of company stock valued at $29,658,802. Company insiders own 0.31% of the company’s stock.

Hedge Funds Weigh In On Lam Research

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. PMV Capital Advisers LLC purchased a new stake in shares of Lam Research in the 4th quarter valued at about $25,000. Stance Capital LLC purchased a new position in shares of Lam Research during the third quarter worth about $26,000. Bayban bought a new position in shares of Lam Research in the fourth quarter worth approximately $26,000. Howard Hughes Medical Institute purchased a new stake in Lam Research in the second quarter valued at approximately $27,000. Finally, Triumph Capital Management purchased a new stake in Lam Research in the third quarter valued at approximately $27,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.